Deep Brain Reorienting (DBR) Processing and Group Intervention for People With Complex Dissociative Disorder
Integrating Individual Deep Brain Reorienting With a Supportive Group Intervention for Complex Dissociative Disorders: A 16-Week Feasibility and Pilot Study
The goal of this pilot clinical trial is to learn whether an integrated 16-week treatment program can be helpful, acceptable, and feasible for adults with complex dissociative disorder (CDD). The program combines individual Deep Brain Reorienting (DBR) therapy with a supportive therapeutic group.
The study is conducted at an outpatient clinic for traume-related disorders in Oslo, Norway, and enrols individuals based on rights to receive specialist treatment in the Norwegian public health system.
The main questions it aims to answer are:
Is it possible to recruit, retain, and treat patients with CDD in this program (feasibility, attendance, drop-out, and treatment tolerability)? How do participants experience receiving DBR together with a supportive group (helpfulness, burden, and suggestions for improvement)? Are there preliminary changes in symptoms, functioning, and quality of life from before to after treatment and at 6-month follow-up? Are two new DBR-specific questionnaires (Where Self Awareness Scale and Shock Induced Vigilance Scale) useful for this patient group? There is no comparison group in this pilot study. All participants receive the same integrated DBR + group intervention.
Participants will:
- Take part in two preparatory individual sessions to receive information about DBR, try the method, and clarify treatment goals.
- Attend a 16-week program with one 45-minute individual DBR session per week and two 30-minute online group sessions per week.
- Join in-person group meetings before the program and a focus group meeting at the end to talk about what was helpful and what could be improved.
- Complete standard questionnaires about trauma-related symptoms before and after treatment, as well as two brief DBR-specific questionnaires at several time points.
- Take part in group interviews right after treatment and 6 months later, and have an individual closing session to summarize their experiences and discuss next steps.
調査の概要
状態
状態
条件
条件
介入・治療
介入・治療
詳細な説明
Integrating Individual Deep Brain Reorienting with a Supportive Group Intervention for Complex Dissociative Disorders:
A 16-Week Feasibility and Pilot Study
-
Background and current state of knowledge Complex dissociative disorders (CDD), including dissociative identity disorder (DID) and other specified dissociative disorder (OSDD), example 1, are severe conditions often associated with early, repeated trauma. They involve dissociation, emotional dysregulation, relational difficulties, and substantial functional impairment. Despite considerable individual and service burden, evidence-based treatment knowledge remains limited.
Trauma-focused treatment is recommended for PTSD generally (NICE). Although emerging evidence supports its use in complex trauma, highly dysregulated patients may require a phase-oriented approach. International guidelines for CDD recommend initial stabilisation and skills training before trauma processing. However, treatment may become prolonged, and many patients never reach the trauma-processing phase.
Only two RCTs have specifically examined interventions for CDD. Finding Solid Ground, a psychoeducational skills programme, showed benefit as an adjunct to individual therapy. In another trial, a 20-week psychoeducational group intervention and standard individual therapy both improved functioning, but the group intervention provided no additional benefit and symptom reduction was limited. No RCTs have evaluated trauma-focused exposure treatment in CDD.
Deep Brain Reorienting (DBR) is a transdiagnostic trauma treatment informed by neuropsychological and neurobiological research. It aims to process the physiological shock response associated with threat or relational injury, focusing on orienting and fear responses rather than detailed trauma narratives. DBR may therefore allow work with current triggers and underlying trauma responses without activating overwhelming memories or affect.
In an RCT, eight web-based DBR sessions produced substantial reductions in PTSD symptoms compared with a waitlist condition, maintained at three-month follow-up. DBR may be effective and tolerable, but it has not been evaluated in CDD.
The field has so far not identified methods that can safely address the traumatic events and the causes of dissociative symptoms early in treatment, before patients have built significant capacity through extended stabilization work. For some patients this can take a very long time, and some never reach genuine trauma processing. DBR appears to be a promising approach for working with the "imprint" of trauma without necessarily having to activate the trauma memories themselves, and may potentially enable earlier processing than what has been common so far. This constitutes the background for the present study. This study therefore examines the feasibility of DBR for this patient group and its potential to support earlier trauma processing.
-
Aim and research questions This feasibility/pilot study evaluates a 16-week integrated treatment programme for patients with complex dissociative disorders (CDD), combining individual DBR with a supportive group intervention at the Trauma Outpatient Clinic, Modum Bad.
The study will examine:
- Feasibility and acceptability: recruitment, attendance, dropout, tolerability, and treatment integrity, as well as participants' experiences of benefits, burden, and potential improvements.
- Preliminary clinical outcomes: changes in symptoms, functioning, and quality of life from pre- to post-treatment and at 6-month follow-up.
- DBR-specific measures: the usefulness and meaningfulness of two new DBR-specific measures, both for research and for supporting participants' own processing.
The findings will inform further development of the programme and a potential larger controlled study.
3. Description of the intervention
The intervention is delivered on an outpatient basis at the Trauma Outpatient Clinic and includes:
-
1-3 preparatory individual sessions to assess symptoms and treatment goals, and to introduce the method.
-
Two initial group sessions will provide:
-
psychoeducation about the background and rationale for the method and how it is conducted,
-
introduce and practice a central orienting exercise ("Where Self"),
-
work to establish a safe and supportive group climate.
-
16 weeks of treatment, consisting of:
-
one weekly individual DBR session with a DBR-trained therapist at the Trauma Outpatient Clinic,
-
two brief digital group meetings per week:
-
the first to identify a suitable focus or issue for the upcoming DBR session and to practice "Where Self" to strengthen orienting capacity,
-
the second focusing on further adaptation of "Where Self" and deepening new perspectives and experiences arising from the DBR processing.
-
During the treatment period, self-report data will be collected,
-
After 16 weeks: one individual summary session and one focus group interview
-
After 6 months: a new focus group interview and completion of self-report questionnaires
4. Rationale for choice of design, data, and methods The aim of the study is to examine (a) feasibility and acceptability of a DBR-based combined individual and group program for patients with CDD, (b) participants' experiences of taking part in the program, and (c) preliminary changes in symptoms, functioning, and quality of life.
A mixed-methods approach:
-
Quantitative data (pre-post and 6-month follow-up) from self-report questionnaires make it possible to describe trends in change in symptoms and functioning, and to test two new DBR-specific measures (Where Self Awareness Scale, Shock Induced Vigilance Scale).
-
Qualitative data from focus group interviews provide access to participants' own descriptions of how they experienced the treatment, what they found helpful or challenging, and how the program can be improved.
6. Research participants and recruitment The study will include 10 adult patients with dissociative identity disorder (DID) or other specified dissociative disorder (OSDD), example 1, who have been referred to the Trauma Outpatient Clinic at Modum Bad.
As a feasibility/pilot study, the sample is not intended to provide sufficient statistical power to determine treatment effectiveness. However, it is considered adequate to explore preliminary clinical changes, assess feasibility parameters (recruitment, attendance, dropout, and tolerability), and collect qualitative data on participants' experiences.
Patients referred to the clinic are assessed according to standard procedures, including consideration of the most appropriate treatment option. Patients considered suitable for the DBR programme will receive verbal and written information about the study and be invited to an assessment session for further information and discussion.
7. Analysis The qualitative data from the focus groups will be suitable for hermeneutic-phenomenological analysis, with the aim of illuminating participants' experiences of the treatment, how they understand their own change processes, and what adjustments to the program they propose.
The quantitative pre-post measures will be analysed descriptively and with simple statistical analyses to explore possible trends in change in symptoms, functioning, and quality of life, and to assess the usefulness of the DBR-specific questionnaires (Where Self Awareness Scale and Shock Induced Vigilance Scale) as outcome and process measures.
Given the small sample, the analyses will be exploratory and hypothesis-generating, not conclusive.
8. Ethical considerations: potential benefits and burdens Potential benefits
- Participation may be meaningful and validating for an underrepresented patient group, and may inform future trauma treatment.
- Participants receive a structured programme combining DBR and group intervention, which may improve symptoms, functioning, and sense of coherence; benefits cannot be guaranteed.
- The study may support development of specialist mental health services for people with CDD, an under-researched group.
Possible burdens
- Questionnaires and focus group interviews may be experienced as demanding.
- Reporting symptoms and trauma-related difficulties, particularly for the first time, may evoke emotional reactions or increased awareness of difficulties.
- Patients who want treatment but not research participation may perceive indirect pressure related to treatment access. This will be addressed through clear information about voluntariness and alternative treatment options.
To minimise these risks, participants will receive oral and written information about the study procedures, the voluntary nature of participation, and their right to withdraw at any time without consequences for their treatment. Alternative treatment options will be discussed where relevant. Assessments will be conducted at the treatment site, with support from project staff available if needed. Focus group interviews will address experiences of treatment rather than traumatic events, and participants may take breaks, decline questions, or limit what they share. Across study procedures, the focus will be on present-day experiences, coping, and treatment processes rather than detailed trauma narratives. The project staff are experienced trauma clinicians trained to manage emotional reactions.
Overall, the research-related burden is considered moderate and comparable to that associated with routine treatment at the Trauma Outpatient Clinic. The potential benefits for participants, the patient group, and future service development are considered to outweigh these burdens.
9. Justification of the project Participation in the project is voluntary, and the DBR intervention is not yet part of the standard treatment offering. Patients who do not wish to participate in the project will be cared for through other treatment options at the clinic.
Previous clinical experience with DBR suggests that the method is well tolerated and perceived as helpful. These experiences have informed the planning of the study. The project staff assess that most participants will find it meaningful to provide feedback on their treatment and contribute to the development of the field.
The benefits of the study (the possibility of improved treatment offerings for a highly vulnerable patient group, and knowledge development in an area with substantial knowledge gaps) are judged to outweigh the risks of burden associated with participation. Given the established measures to protect participants, the project is considered ethically justifiable.
10. Information, consent, and data protection
-
Written informed consent will be obtained from all participants prior to inclusion.
-
Participants will be informed about the purpose, methods, voluntary nature of participation, right to withdraw, and how data will be handled.
-
Data will be collected in de-identified form using a code. The key linking codes to personal identity will be stored in a secure area on Modum Bad's servers, accessible only to the project leader.
-
Audio recordings from focus group interviews will be transcribed and de-identified on a PC without internet access; the audio files will then be deleted. Transcripts and questionnaire data will be stored on secure servers at Modum Bad.
-
A Data Protection Impact Assessment (DPIA) will be carried out at the institution, and the project will not commence until this has been approved by the local responsible authority at Modum Bad.
11. Implementation plan and organization
-
Project leader:
Peter Sele, PhD, Acting Head of Research at Modum Bad.
- Project responsible (day-to-day management, adherence to procedures, data collection, analysis, dissemination):
- Ingunn Holbæk, clinical psychologist specialist and PhD candidate with many years of specialization in complex dissociative disorders and several publications in the field.
- Project staff:
- Katinka Thorne Salvesen, clinical psychologist specialist with many years of specialization in complex dissociative disorders and several publications in the field.
Both the project responsible and the project staff member have additional training in body-oriented trauma treatment (Sensorimotor Psychotherapy), EMDR, Narrative Exposure Therapy, and DBR, and more than 20 years of clinical experience with this patient group.
The Trauma Outpatient Clinic aims to be innovative and contribute to the development of more effective treatment methods. The clinic leader supports the project. Modum Bad has its own research department with available resources that has been involved from the project planning phase.
User involvement is ensured by systematically collecting patients' experiences through focus group interviews and using these to improve the treatment model.
Frank Corrigan (psychiatrist, developer of DBR) has contributed input on the study design and provided relevant DBR-specific questionnaires. He will provide clinical supervision to the therapists to ensure good treatment integrity.
12. Dissemination of results
There are no restrictions on publication. The results will:
- be published in scientific articles in peer-reviewed journals,
- be presented at national and international trauma conferences,
- potentially be disseminated in professional forums, seminars, and internal teaching sessions at Modum Bad.
All dissemination will be at an aggregated level and in a form that makes it impossible to identify individual participants.
研究の種類
研究の種類
入学 (推定)
入学
段階
段階
- 適用できない
連絡先と場所
研究場所
-
-
-
Oslo、ノルウェー、0251
- Modum Bad, Out patient Trauma clinic
-
-
参加基準
適格基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Age ≥ 18 years
- Meets criteria for complex dissociative disorder (DID or OSDD, example 1; e.g. F44.88/F44.81)
- Referred to the Trauma Outpatient Clinic
- Own motivation to participate in the DBR intervention and the associated group program
Exclusion Criteria:
-
Ongoing severe substance abuse
- Violent behavior
- Severe current crisis
- Ongoing high risk of suicide
- Psychotic disorder
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:なし
- 介入モデル:単一グループの割り当て
- マスキング:なし(オープンラベル)
アーム数
武器と介入
参加者グループ / アーム参加者グループ / アーム |
介入・治療介入・治療 |
|---|---|
|
実験的:Integrated DBR plus Supportive Group Intervention
Participants receive a 16-week integrated treatment program combining individual Deep Brain Reorienting (DBR) with a supportive group intervention. The program includes 1-3 preparatory individual sessions, two initial in-person psychoeducational group meetings, 16 weekly individual DBR sessions (45 minutes), and two brief digital group meetings per week focused on orienting practice ("Where Self") and integration of DBR experiences. After treatment, participants attend a focus group interview and complete follow-up assessments at post-treatment and 6 months. |
Participants receive 1-3 preparatory individual sessions for assessment, psychoeducation about Deep Brain Reorienting (DBR), and demonstration of the method, followed by 16 weekly individual DBR sessions (45 minutes each) delivered by DBR-trained therapists. DBR is a trauma-focused psychotherapy that targets the orienting and shock responses linked to threatening or attachment-related experiences, using present-moment orienting as an anchor to process subcortical shock responses without necessarily activating full trauma memories.
他の名前:
Participants attend two initial in-person group sessions providing psychoeducation about DBR, introduction and practice of the "Where Self" orienting exercise, and establishment of a safe group climate. During the 16-week program, participants attend two brief digital group meetings per week: one to identify a focus or trigger for the upcoming individual DBR session and practice "Where Self", and one to further adapt "Where Self" and reflect on experiences and new perspectives from DBR processing. After the 16-week program and at 6-month follow-up, participants also attend focus group interviews to discuss their experiences of the combined DBR and group intervention.
他の名前:
|
この研究は何を測定していますか?
主要な結果の測定
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Feasibility of recruitment, retention and attendance
時間枠:From study start to end of 16-week treatment program (approximately 6-9 months, depending on recruitment period)
|
Feasibility will be evaluated by: recruitment rate (number of eligible patients enrolled / number of eligible patients approached), proportion of participants initiating treatment, and retention rate (number and percentage of participants completing the 16-week program). These indicators will be extracted from clinic and study records. |
From study start to end of 16-week treatment program (approximately 6-9 months, depending on recruitment period)
|
|
Participant-reported acceptability and tolerability of the integrated DBR and group intervention
時間枠:Post-treatment (immediately after the 16-week program)
|
Acceptability and tolerability will be assessed with qualitative data from post-treatment focus group interviews (thematic analysis of perceived benefits, burdens, and suggestions for improvement). |
Post-treatment (immediately after the 16-week program)
|
二次結果の測定
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
PTSD symptom severity assessed by the PTSD Checklist for DSM-5 (PCL-5)
時間枠:Baseline (pre-treatment), post-treatment (16 weeks), and 6-month follow-up
|
PTSD symptom severity will be assessed using the PTSD Checklist for DSM-5 (PCL-5). . |
Baseline (pre-treatment), post-treatment (16 weeks), and 6-month follow-up
|
|
Dissociative symptom severity assessed by the Dissociative Experiences Scale (DES)
時間枠:Baseline (pre-treatment), post-treatment (16 weeks), and 6-month follow-up.
|
Dissociative symptom severity will be assessed using the Dissociative Experiences Scale (DES). DES total scores will be assessed. |
Baseline (pre-treatment), post-treatment (16 weeks), and 6-month follow-up.
|
|
Psychological distress and functioning assessed by the Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM)
時間枠:Baseline (pre-treatment), post-treatment (16 weeks), and 6-month follow-up.
|
Psychological distress and functioning will be assessed using the Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM). Overall mean scores will be assessed at baseline, post-treatment, and 6-month follow-up. |
Baseline (pre-treatment), post-treatment (16 weeks), and 6-month follow-up.
|
|
Orienting and self-awareness assessed by the Where Self Awareness Scale
時間枠:Baseline (pre-treatment), mid-treatment (approximately 8 weeks), post-treatment (16 weeks), and 6-month follow-up.
|
The Where Self Awareness Scale is a DBR-specific measure of orienting and self-awareness in relation to shock and threat responses. Scores will be assessed at baseline, mid-treatment, post-treatment, and 6-month follow-up. Feasibility of administration, score distributions, and patterns of scores over time will be explored. |
Baseline (pre-treatment), mid-treatment (approximately 8 weeks), post-treatment (16 weeks), and 6-month follow-up.
|
|
Shock-related vigilance assessed by the Shock Induced Vigilance Scale
時間枠:Before each individual DBR session during the 16-week treatment programme (up to 16 assessments) and at 6-month follow-up.
|
The Shock Induced Vigilance Scale is a DBR-specific measure of vigilance and activation related to shock responses. The measure will be administered before each individual DBR session (up to 16 assessments) and at 6-month follow-up. Feasibility of administration, interpretability, and patterns of scores over time will be explored. |
Before each individual DBR session during the 16-week treatment programme (up to 16 assessments) and at 6-month follow-up.
|
協力者と研究者
捜査官
捜査官
- スタディディレクター:KariAnne Vrabel, Professor、Modum Bad; Reseach Institute
研究記録日
主要日程の研究
研究開始 (実際)
研究開始
一次修了 (推定)
一次修了
研究の完了 (推定)
研究の完了
試験登録日
最初に提出
最初に提出
QC基準を満たした最初の提出物
QC基準を満たした最初の提出物
最初の投稿 (実際)
最初の投稿
学習記録の更新
投稿された最後の更新 (実際)
投稿された最後の更新
QC基準を満たした最後の更新が送信されました
QC基準を満たした最後の更新が送信されました
最終確認日
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
その他の研究ID番号
- REK987405
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
Data sharing is not planned and is regulated by the the ethics approval from The Regional Committees for Medical and Health Research Ethics (REK). Anonymized data will be made available upon reasonable request.
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。